Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0DHVBP
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2024043319A1 79
|
|||||
| Synonyms |
WO2024043319A1 WO2024043319A1 79
Click to Show/Hide
|
|||||
| Organization |
EISAI R&D MANAGEMENT CO., LTD.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.5
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Receptor-type tyrosine-protein kinase FLT3 (FLT3)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||